Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

ClinicalTrials.gov identifiers: NCT03131648 (registered 24 April 2017), NCT03160885 (registered 18 May 2017), NCT03363854 (registered 01 December 2017), and NCT03587805 (registered 03 July 2018).

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Dermatology
Published
2025-10-21
DOI
https://doi.org/10.1007/s40257-025-00985-1
Citations
1
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
2.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

Melinda Gooderham, Jonathan I. Silverberg, Kenji Kabashima, Emma Guttman‐Yassky et al.
1 citations
American Journal of Clinical Dermatology
Dermatology and Skin Diseases
2.00
article

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

Melinda Gooderham, Jonathan I. Silverberg, Kenji Kabashima, Emma Guttman‐Yassky, Ben Esdaile, Shannon Schneider, Mads A. Røpke, April Wang Armstrong, Andrew F Alexis, Rie von Eyben, Leon Kircik, Niels H. Bennike, Britta C. Martel, Andrew Blauvelt, Tiffany Mayo, Norito Katoh
article en
1 citations

Abstract

ClinicalTrials.gov identifiers: NCT03131648 (registered 24 April 2017), NCT03160885 (registered 18 May 2017), NCT03363854 (registered 01 December 2017), and NCT03587805 (registered 03 July 2018).

American Journal of Clinical DermatologyVol. 27(1)
University of California, Los Angeles (US), George Washington University (US), Queen's University (CA), Cornell University (US), Kyoto University (JP), University of Alabama at Birmingham (US), Kyoto Prefectural University of Medicine (JP), Maryland Department of Natural Resources (US), Probity Medical Research (CA), Whittington Health NHS Trust (GB), Leo Pharma (United States) (US), Leo Pharma (Denmark) (DK), Weill Cornell Medicine (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), Icahn School of Medicine at Mount Sinai (US)
LEO Pharma
Openalex Percentile: Top 11%
Dermatology and Skin Diseases
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.